Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 233

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors

Open access
Shomuradova, Alina S., Vagida, Murad S., Sheetikov, Savely A., Zornikova, Ksenia V., Kiryukhin, Dmitry, Titov, Aleksei, Peshkova, Iuliia O., Khmelevskaya, Alexandra, Dianov, Dmitry V., Malasheva, Maria, Shmelev, Anton, Serdyuk, Yana, Bagaev, Dmitry V., Pivnyuk, Anastasia, Shcherbinin, Dmitrii S., Maleeva, Alexandra V., Shakirova, Naina T., Pilunov, Artem, Malko, Dmitry B., Khamaganova, Ekaterina G., Biderman, Bella, Ivanov, Alexander, Shugay, Mikhail, Efimov, Grigory A.·2020·Immunity

Published version of a preprint

Abstract

Understanding the determinants of adaptive immune response to SARS-CoV-2 is critical for fighting the ongoing COVID-19 pandemic. Here we assayed both antibody and T-cell reactivity to SARS-CoV-2 antigens in COVID-19 convalescent patients and healthy donors sampled before and during the pandemic. Our results show that while anti-SARS-CoV-2 antibodies can distinguish convalescent patients from healthy donors, the magnitude of T-cell response was more pronounced in healthy donors sampled during COVID-19 pandemic than in donors sampled before the outbreak. This hints at the possibility that some individuals have encountered the virus but were protected by T-cell cross-reactivity observed. A public and diverse T-cell response was observed for two A*02-restricted SARS-CoV-2 epitopes, revealing a set of T-cell receptor motifs displaying germline-encoded features. Bulk CD4+ and CD8+ T-cell response to SARS-CoV-2 glycoprotein S is characterized by multiple groups of homologous T-cell receptor sequences some of which are shared across multiple donors, indicating the existence of immunodominant epitopes. Overall, our findings indicate that T cells form an efficient response to SARS-CoV-2 and alongside the antibodies can serve as a useful biomarker for surveying SARS-CoV-2 exposure and immunity. We hope that data, including the set of specific T-cell receptors identified in this study can serve as a basis for future developments of SARS-CoV-2 vaccinations and monitoring.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2020.11.004

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 57

  1. Ahmed, 2020, Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies, Viruses, 12, 254, 10.3390/v12030254 · DOI · Paper page
  2. Bagaev, 2019, VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium, Nucleic Acids Research, 48, 10.1093/nar/gkz874 · DOI · Paper page
  3. Bakker, 2008, Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7, Proc. Natl. Acad. Sci. U S A, 105, 3825, 10.1073/pnas.0709717105 · DOI
  4. Baruah, 2020, Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV, J. Med. Virol., 92, 495, 10.1002/jmv.25698 · DOI · Paper page
  5. Bovay, 2018, T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus, Eur. J. Immunol., 48, 258, 10.1002/eji.201747082 · DOI
  6. Chen, 2017, Sequence and structural analyses reveal distinct and highly diverse human CD8+ TCR repertoires to immunodominant viral antigens, Cell Rep., 19, 569, 10.1016/j.celrep.2017.03.072 · DOI
  7. Chen, 2010, Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection, J. Virol., 84, 1289, 10.1128/JVI.01281-09 · DOI · Paper page
  8. Chen, 2020, Convalescent plasma as a potential therapy for COVID-19, Lancet Infect. Dis., 20, 398, 10.1016/S1473-3099(20)30141-9 · DOI · Paper page
  9. Culshaw, 2017, Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response, Nat. Immunol., 18, 1228, 10.1038/ni.3850 · DOI
  10. Danilova, 2018, The mutation-associated neoantigen functional expansion of specific T cells (MANAFEST) assay: a sensitive platform for monitoring antitumor immunity, Cancer Immunol. Res., 6, 888, 10.1158/2326-6066.CIR-18-0129 · DOI · Paper page
  11. Fan, 2009, Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection, Arch. Virol., 154, 1093, 10.1007/s00705-009-0409-6 · DOI
  12. Gallais, 2020, Intrafamilial exposure to SARS-CoV-2 induces cellular immune response without seroconversion, medRxiv
  13. Gangaev, 2020, Profound CD8 T cell responses towards the SARS-CoV-2 ORF1ab in COVID-19 patients, Research Square
  14. Grifoni, 2020, A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2, Cell Host Microbe, 27, 671, 10.1016/j.chom.2020.03.002 · DOI · Paper page
  15. Guo, 2020, Profiling early humoral response to diagnose novel coronavirus disease (COVID-19), Clin. Infect. Dis., 71, 778, 10.1093/cid/ciaa310 · DOI · Paper page
  16. Huang, 2020, A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity, Nat. Commun., 11, 4704, 10.1038/s41467-020-18450-4 · DOI · Paper page
  17. Ishizuka, 2009, Quantitating T cell cross-reactivity for unrelated peptide antigens, J. Immunol., 183, 4337, 10.4049/jimmunol.0901607 · DOI
  18. Krammer, 2020, Serology assays to manage COVID-19, Science, 368, 1060, 10.1126/science.abc1227 · DOI · Paper page
  19. Lee, 2020, In silico identification of vaccine targets for 2019-nCoV, F1000Res., 9, 145, 10.12688/f1000research.22507.2 · DOI
  20. Li, 2008, T cell responses to whole SARS coronavirus in humans, J. Immunol., 181, 5490, 10.4049/jimmunol.181.8.5490 · DOI · Paper page
  21. Li, 2004, Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome, J. Infect. Dis., 189, 648, 10.1086/381535 · DOI · Paper page
  22. Lillie, 2020, Novel coronavirus disease (COVID-19): the first two patients in the UK with person to person transmission, J. Infect., 80, 578, 10.1016/j.jinf.2020.02.020 · DOI · Paper page
  23. Lv, 2009, Identification of a novel conserved HLA-A∗0201-restricted epitope from the spike protein of SARS-CoV, BMC Immunol., 10, 61, 10.1186/1471-2172-10-61 · DOI
  24. Miles, 2011, Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection, J. Immunol., 186, 901, 10.4049/jimmunol.1003167 · DOI
  25. Minervina, 2020, Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection, bioRxiv
  26. Minervina, 2020, Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones, eLife, 9, e53704, 10.7554/eLife.53704 · DOI
  27. Ng, 2016, Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection, Vaccine, 34, 2008, 10.1016/j.vaccine.2016.02.063 · DOI · Paper page
  28. Nguyen, 2020, Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2, J. Virol., 10.1128/JVI.00510-20 · DOI · Paper page
  29. Ni, 2020, Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals, Immunity, 52, 971, 10.1016/j.immuni.2020.04.023 · DOI · Paper page
  30. Nielsen, 2005, The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage, Immunogenetics, 57, 33, 10.1007/s00251-005-0781-7 · DOI · Paper page
  31. Phan, 2020, In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19, bioRxiv
  32. Phelan, 2020, The novel coronavirus originating in Wuhan, China: challenges for global health governance, JAMA, 323, 709, 10.1001/jama.2020.1097 · DOI · Paper page
  33. Pinto, 2020, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature, 583, 290, 10.1038/s41586-020-2349-y · DOI · Paper page
  34. Pogorelyy, 2018, Exploring the pre-immune landscape of antigen-specific T cells, Genome Med., 10, 68, 10.1186/s13073-018-0577-7 · DOI
  35. Pogorelyy, 2019, A framework for annotation of antigen specificities in high-throughput T-Cell repertoire sequencing studies, Front. Immunol., 10, 2159, 10.3389/fimmu.2019.02159 · DOI
  36. Price, 2004, T cell receptor recognition motifs govern immune escape patterns in acute SIV infection, Immunity, 21, 793, 10.1016/j.immuni.2004.10.010 · DOI · Paper page
  37. Reynisson, 2020, NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data, Nucleic Acids Res., 48, W449, 10.1093/nar/gkaa379 · DOI · Paper page
  38. Ritvo, 2018, High-resolution repertoire analysis reveals a major bystander activation of Tfh and Tfr cells, Proc. Natl. Acad. Sci. U S A, 115, 9604, 10.1073/pnas.1808594115 · DOI
  39. Rodenko, 2006, Generation of peptide-MHC class I complexes through UV-mediated ligand exchange, Nat. Protoc., 1, 1120, 10.1038/nprot.2006.121 · DOI · Paper page
  40. Rogers, 2020, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, Science, 369, 956, 10.1126/science.abc7520 · DOI · Paper page
  41. Romero-López, 2020, Prediction of SARS-CoV2 spike protein epitopes reveals HLA-associated susceptibility, Research Square
  42. Rubelt, 2017, Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data, Nat. Immunol., 18, 1274, 10.1038/ni.3873 · DOI · Paper page
  43. Schultheiß, 2020, Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease, Immunity, 53, 442, 10.1016/j.immuni.2020.06.024 · DOI · Paper page
  44. Shanmugaraj, 2020, Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19), Asian Pac. J. Allergy Immunol., 38, 10
  45. Thevarajan, 2020, Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19, Nat. Med., 26, 453, 10.1038/s41591-020-0819-2 · DOI · Paper page
  46. Wang, 2004, Identification of an HLA-A∗0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein, Blood, 104, 200, 10.1182/blood-2003-11-4072 · DOI
  47. Wang, 2020, A human monoclonal antibody blocking SARS-CoV-2 infection, Nat. Commun., 11, 2251, 10.1038/s41467-020-16256-y · DOI · Paper page
  48. Wang, 2004, T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS, J. Virol., 78, 5612, 10.1128/JVI.78.11.5612-5618.2004 · DOI
  49. Wong, 2003, Treatment of severe acute respiratory syndrome with convalescent plasma, Hong Kong Med. J., 9, 199
  50. Wu, 2020, Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications, medRxiv
  51. Yang, 2007, Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen, J. Gen. Virol., 88, 2740, 10.1099/vir.0.82839-0 · DOI
  52. Yang, 2006, Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients, Clin. Immunol., 120, 171, 10.1016/j.clim.2006.05.002 · DOI
  53. Zheng, 2020, Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients, Cell. Mol. Immunol., 17, 541, 10.1038/s41423-020-0401-3 · DOI · Paper page
  54. Zhou, 2006, Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes, J. Immunol., 177, 2138, 10.4049/jimmunol.177.4.2138 · DOI
  55. Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
  56. Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 · DOI · Paper page
  57. Zvyagin, 2017, Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children, Leukemia, 31, 1145, 10.1038/leu.2016.321 · DOI

Cited by

See all 233

Metadata

Authors
Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D., Titov, A., Peshkova, I. O., Khmelevskaya, A., Dianov, D. V., Malasheva, M., Shmelev, A., Serdyuk, Y., Bagaev, D. V., Pivnyuk, A., Shcherbinin, D. S., Maleeva, A. V., Shakirova, N. T., Pilunov, A., Malko, D. B., Khamaganova, E. G., Biderman, B., Ivanov, A., Shugay, M., & Efimov, G. A.
Venue
Immunity
Publisher
Elsevier BV
Published
2020-12
Volume
53
Issue
6
Pages
1245-1257.e5
ISSN
1074-7613 (ISSN-L)
OpenAlex
W3103140952
Cited by
233
References
16
FWCI
5.43
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Russian Science Foundation (20-15-00395)
  • Russian Foundation for Basic Research (19-34-70011, 075-15-2019-1660)
  • Ministry of Science and Higher Education of the Russian Federation (075-15-2019-1789)
  • Ministry of Education and Science of the Russian Federation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors. https://app.cochat.ai/papers/10.1016/j.immuni.2020.11.004
The paper
Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D., Titov, A., Peshkova, I. O., Khmelevskaya, A., Dianov, D. V., Malasheva, M., Shmelev, A., Serdyuk, Y., Bagaev, D. V., Pivnyuk, A., Shcherbinin, D. S., Maleeva, A. V., Shakirova, N. T., Pilunov, A., Malko, D. B., . . . Efimov, G. A. (2020). SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors. Immunity. https://doi.org/10.1016/j.immuni.2020.11.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.